Despite beating EPS estimates by 76%, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends ahead of earnings. The stock is expected to underperform the market in the near term, and the industry outlook is weak, ranking in the bottom 32% of sectors.
Articles that tag ANAB but are mainly about other companies.
Court ruling favors Anaptys by dismissing Tesaro's anticipatory breach claim and rejecting royalty reduction requests. The decision validates Anaptys' legal position and preserves current royalty rates (8-25% tiered structure). Upcoming trial presents opportunity to enforce additional contractual rights and potentially regain Jemperli reversion.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
